Altre lingue Piramal Pharma Limited

Azioni

PPLPHARMA

INE0DK501011

Mercato chiuso - NSE India S.E. Altri mercati azionari 13:43:53 06/05/2024			Variaz. 5gg	Var. 1 gen.
156 ^INR	+3,28%		+9,67%	+12,35%

10/04	Piramal Pharma Limited annuncia il lancio della gamma di prodotti BOHEM	CI
31/01	Transcript : Piramal Pharma Limited, Q3 2024 Earnings Call, Jan 31, 2024

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Piramal Pharma Limited Receives Assessment Orders from the Office of the Navi Mumbai Municipal Corporation, Cess Department	27/04
Piramal Pharma Limited Receives Order from the Regional Provident Fund Commissioner, Thane South, Levying Damages of INR 1,120,932 Under Bombay Provincial Municipal Corporation (Cess on Entry of Goods) Rules, 1996	19/04
Piramal Pharma Gets US FDA's Establishment Inspection Report for Riverview, US Facility	18/04
Los mercados de India cierran a la baja en medio de sentimientos tibios de los inversores -- Market Talk	12/04
Piramal Pharma Forays into Men Grooming Products	10/04
Piramal Pharma Limited Announces the Launch of BOHEM Product Range	10/04
Piramal Pharma Turns to Profit in Fiscal Q3	31/01
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024	30/01
Piramal Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	30/01
PIRAMAL PHARMA SOLUTIONS COMMEMORATES OPENING OF ITS ADC MANUFACTURING EXPANSION IN GRANGEMOUTH, SCOTLAND	18/12
Piramal Pharma Solutions Commences Opening of Its Antibody-Drug Conjugate Manufacturing Expansion in Grangemouth, Scotland	18/12
FOCUS -Indian drug manufacturers benefit from Big Pharma interest beyond China	27/11
Piramal Pharma Gets US FDA's EIR Report After Bethlehem, USA Unit Inspection	09/11
Piramal Pharma Swings to Profit in Fiscal Q2	30/10/23
Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2024	28/10/23
Piramal Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	27/10/23
Piramal Pharma Solutions Launches In-Vitro Biology Capabilities At Ahmedabad Discovery Services Site	16/10/23
Piramal Pharma Gets Two Observations from US FDA After Inspection of US Facility	29/09/23
Piramal Pharma Gets Regulatory Nod to Liquidate Japanese Arm	12/09/23
Piramal Pharma Limited Announces Consolidated Results for Q1FY24	04/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Piramal Pharma Limited

Azioni

PPLPHARMA

INE0DK501011

Altre lingue

Filtri